Staphylococcus epidermidis modulates EMT-related gene expression and viability in MDA-MB-231 breast cancer cells
Abstract
Background and Objectives: Breast tissue microbiota differs between healthy and cancerous tissues, with some bacteria influencing tumor progression. Staphylococcus epidermidis, a common skin commensal found in breast tumors, may play a role in epithelial-mesenchymal transition (EMT), a key step in metastasis. This study evaluated the effects of S. epidermidis culture and cell-free supernatant (CFS) on MDA-MB-231 breast cancer cell survival and expression of EMT-related genes Snail1, fibronectin 1 (FN1), and N-cadherin (CDH2).
Materials and Methods: Different concentrations of S. epidermidis cultures and their CFS were applied to MDA-MB-231 cells. Cytotoxic effects were assessed by MTT assay at 2, 4, and 24 hours post-treatment. Real-time PCR analyzed gene expression after 24 hours of exposure to non-toxic concentrations (MOI 50 and 100 for cultures; 14% for CFS).
Results: Low concentrations did not affect viability, while higher doses (MOI 100 and 14% CFS) reduced viability by up to 60% and 90%, respectively, at 24 hours. MOI 50 did not significantly alter gene expression. At MOI 100, Snail1 and FN1 were significantly upregulated, but CDH2 was unchanged. Treatment with 5% and 7% CFS significantly increased all three EMT gene expressions, indicating EMT induction.
Conclusion: S. epidermidis affects EMT gene expression and cell viability, indicating potential involvement in breast cancer progression.
2. Thu MS, Chotirosniramit K, Nopsopon T, Hirankarn N, Pongpirul K. Human gut, breast, and oral microbiome in breast cancer: A systematic review and meta-analysis. Front Oncol 2023; 13: 1144021.
3. Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer 2018; 18: 128-134.
4. Liu J, Luo F, Wen L, Zhao Z, Sun H. Current understanding of microbiomes in cancer metastasis. Cancers (Basel) 2023; 15: 1893.
5. Bernardo G, Le Noci V, Ottaviano E, De Cecco L, Camisaschi C, Guglielmetti S, et al. Reduction of Staphylococcus epidermidis in the mammary tumor microbiota induces antitumor immunity and decreases breast cancer aggressiveness. Cancer Lett 2023; 555: 216041.
6. Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G. The microbiota of breast tissue and its association with breast cancer. Appl Environ Microbiol 2016; 82: 5039-5048.
7. Guo H. Interactions between the tumor microbiota and breast cancer. Front Cell Infect Microbiol 2025; 14: 1499203.
8. Allen-Taylor D, Boro G, Cabato PM, Mai C, Nguyen K, Rijal G. Staphylococcus epidermidis biofilm in inflammatory breast cancer and its treatment strategies. Biofilm 2024; 8: 100220.
9. Perez K, Patel R. Survival of Staphylococcus epidermidis in fibroblasts and osteoblasts. Infect Immun 2018; 86(10): e00237-18.
10. Dong Y, Glaser K, Schlegel N, Claus H, Speer CP. An underestimated pathogen: Staphylococcus epidermidis induces pro-inflammatory responses in human alveolar epithelial cells. Cytokine 2019; 123: 154761.
11. Kim HE, Kim J, Maeng S, Oh B, Hwang KT, Kim BS. Microbiota of breast tissue and its potential association with regional recurrence of breast cancer in Korean women. J Microbiol Biotechnol 2021; 31: 1643-1655.
12. Carretero-Fernández M, Cabrera-Serrano AJ, Sánchez-Maldonado JM, Ruiz-Durán L, Jiménez-Romera F, García-Verdejo FJ, et al. Autophagy and oxidative stress in solid tumors: Mechanisms and therapeutic opportunities. Crit Rev Oncol Hematol 2025; 212: 104820.
13. Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep 2016; 6: 30751.
14. Ji G, Zhao J, Si X, Song W. Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria. Adv Drug Deliv Rev 2024; 211: 115345.
15. Kim S, Kim HE, Kang B, Lee YW, Kim H, Chung DK. Lipoteichoic acid isolated from Staphylococcus aureus induces both epithelial-mesenchymal transition and wound healing in HaCaT cells. Microbiol Biotechnol 2017; 27: 1820-1826.
16. Singh S, Chakrabarti R. Consequences of EMT-driven changes in the immune microenvironment of breast cancer and therapeutic response of cancer cells. J Clin Med 2019; 8: 642.
Files | ||
Issue | Vol 17 No 5 (2025) | |
Section | Original Article(s) | |
DOI | https://doi.org/10.18502/ijm.v17i5.19887 | |
Keywords | ||
Staphylococcus epidermidis Epithelial-mesenchymal transition Breast neoplasms Gene expression Microbiota |
Rights and permissions | |
![]() |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |